Internacional
Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
The drugmaker says Lilly isn't including the most up-to-date clinical information about its drugs
Por Redacción Sinergia Empresarial · 21 de julio de 2026 · 1 min
The drugmaker says Lilly isn't including the most up-to-date clinical information about its drugs
Sinergia Empresarial continuará el seguimiento de esta información sobre novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications y ampliará la cobertura conforme se confirmen nuevos elementos relevantes para el ecosistema empresarial.
